Clinical Trials
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9413
Phase II Treatment with Etoposide (E), Leucovorin (L), 5-Fluorouracil (F) and Interferon Alpha 2b (I), (ELFI) + G-CSF for Locally Advanced or Recurrent Pancreatic Adenocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
05-01-1995
Closed
03-15-1996
Closed
Phase
Accrual
6%
SWOG Clinical Trial Number
SWOG-9432
Closed
Phase
Accrual
95%
Published
SWOG Clinical Trial Number
SWOG-9436 (NABTC-9403) (NCI T94-0184)
A Phase I/II Trial of Paclitaxel (Taxol®) Chemotherapy for Recurrent Malignant Glioma
Research Committee(s)
Brain Cancer
Activated
04-18-1995
Closed
02-04-1998
Closed
Phase
Accrual
40%
Published
SWOG Clinical Trial Number
SWOG-9239
Phase II Trial of Sequential Modification of Immunosuppression, Interferon Alpha, and ProMACE-CytaBOM for Treatment of Post-Organ Transplant Lymphoproliferation
Research Committee(s)
Lymphoma
Activated
04-15-1995
Closed
08-15-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9420
A Phase III Trial of Continuous Low-Dose Infusion versus Intermittent High-Dose Infusion of 5-Fluorouracil in Patients with Disseminated Colorectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-1995
Closed
05-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9416
Induction Chemoradiotherapy Followed by Surgical Resection, for Non-Small Cell Lung Cancer Involving the Superior Sulcus (Pancoast Tumors): A Phase II Trial
Research Committee(s)
Lung Cancer
Activated
04-15-1995
Closed
08-01-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9501
A Phase II Trial of Fludarabine and Mitoxantrone (FN) for Treatment of Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
04-01-1995
Closed
02-15-1996
Closed
Phase
SWOG Clinical Trial Number
SWOG-9419
Tumor Tissue Biopsy for Thymidylate Synthase Expression in Patients with Colorectal Cancer, Ancillary
Research Committee(s)
Gastrointestinal Cancer
Activated
03-15-1995
Closed
08-15-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9426
A Phase II Trial of Antiandrogen Withdrawal In Patients with Progressive Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Activated
03-15-1995
Closed
06-01-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9324
Phase II Trial of Vinorelbine Tartrate (Navelbine®) for Patients with Relapsed Ovarian Cancer
Research Committee(s)
Gynecologic Cancer
Activated
03-15-1995
Closed
07-01-1997
Closed
Phase
Accrual
18%
SWOG Clinical Trial Number
SWOG-9249
Closed
Phase
Accrual
66%
Published
SWOG Clinical Trial Number
SWOG-9445
Prognostic Factor Panel to Predict Preferred Therapy for Node Positive Postmenopausal Breast Cancer Patients (CAF vs. Tamoxifen) (a Companion Protocol to SWOG-8814 [INT-0100, CALGB-9194, EST-4188, NCCTG-883051, NCIC-MA.9])
Research Committee(s)
Breast Cancer
Activated
02-01-1995
Closed
10-01-1998
Closed
Phase
Accrual
84%
Published
SWOG Clinical Trial Number
SWOG-9333
A Randomized Controlled Trial of Mitoxantrone and Etoposide versus Daunomycin and Cytosine Arabinoside as Induction Therapy in Patients Over Age 55 With Previously Untreated Acute Myeloid Leukemia, Phase III
Research Committee(s)
Leukemia
Activated
01-15-1995
Closed
12-01-1998
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
SWOG-9443 (NABTC-9402) (NCI T94-0087)
A Phase II Trial of Phenylacetic Acid for Recurrent Malignant Glioma and Primitive Neuroectodermal Tumors: A Clinical and Pharmacokinetics Study of the North American Brain Tumor Consortium
Research Committee(s)
Brain Cancer
Activated
12-27-1994
Closed
12-15-1997
Closed
Phase
Accrual
31%
Published
SWOG Clinical Trial Number
SWOG-9405
Adequacy Conventional Radiation Therapy Portals to Encompass Locally Advanced Cervix Cancer: An Ancillary Study to SWOG-9318
Activated
12-15-1994
Closed
03-01-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9338
A Phase II Trial of Combination Therapy With 5-Fluorouracil, a-Interferon and Interleukin-2 ("FUNIL") for Advanced Renal Cell Carcinoma
Research Committee(s)
Genitourinary Cancer
Activated
12-15-1994
Closed
09-01-1997
Closed
Phase
Accrual
98%
Published
SWOG Clinical Trial Number
SWOG-9318
Recombinant Human Erythropoietin (r-HuEPO) as an Adjunct to Radiation Therapy and Cisplatin for Patients with Stages II-B, III and IV-A Carcinoma of the Cervix, Phase II
Research Committee(s)
Gynecologic Cancer
Activated
12-15-1994
Closed
03-01-1999
Closed
Phase
Accrual
71%
Published
SWOG Clinical Trial Number
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)
Phase III Randomized Trial of 5-FU/Leucovorin/Levamisole versus 5-FU Continuous Infusion/Levamisole as Adjuvant Therapy for High-Risk Resectable Colon Cancer, Intergroup.
Research Committee(s)
Gastrointestinal Cancer
Activated
12-01-1994
Closed
12-15-1999
Closed
Phase
Accrual
75%
Published
SWOG Clinical Trial Number
SWOG-9424
Phase II Trial of High Dose Tamoxifen Plus Cisplatin Chemotherapy in Metastatic Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
11-15-1994
Closed
12-01-1996
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9341
High-Dose Ifosfamide (HDI) with Mesna and Granulocyte-Colony Stimulating Factor (rhG-CSF) in Unresectable Malignant Mesothelioma
Activated
09-15-1994
Closed
09-15-1996